[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Franczyk M.P., Qi N., Stromsdorfer K.L., Li C., Yamaguchi S., Itoh H., Yoshino M., Sasaki Y., Brookheart R.T., Finck B.N., et al
Weight loss plateaus Every patient on a GLP-1 will eventually stop losing weight
Los medicamentos genricos ofrecen opciones de tratamiento adicionales que, por lo general, son ms asequibles para los pacientes
[10] The first amylin analogue to reach the clinic, pramlintide, demonstrated that the pathway could be drugged, but native-style amylin analogues are short-acting and were used as multiple-daily injections, which limited their appeal for weight management
Together with other modifications in the peptide sequence, this leads to a tirzepatide half-life of over five days [1, 4]